Evidence map›Paper›PMID 36672212›Full record

ReviewCells2023

Macrophages: From Simple Phagocyte to an Integrative Regulatory Cell for Inflammation and Tissue Regeneration-A Review of the Literature.

Andreas Mamilos, Lina Winter, Volker H Schmitt, Friedrich Barsch, David Grevenstein, Willi Wagner, Maximilian Babel, Karsten Keller, Christine Schmitt, Florian Gürtler and 5 more

Abstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Immunogenic cell death unlocks the potential for combined radiation and immunotherapy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. The M2 Macrophages Importance Role in Psoriasis.Immunity, inflammation and disease · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andreas MamilosInstitute of Pathology, University of Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-0895-5675
Lina WinterInstitute of Pathology, University of Regensburg, 93053 Regensburg, Germany.
Volker H SchmittDepartment of Cardiology, University Medical Centre, Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.ORCID 0000-0001-5070-7280
Friedrich BarschMedical Center, Faculty of Medicine, Institute for Exercise and Occupational Medicine, University of Freiburg, 79106 Freiburg, Germany.ORCID 0000-0002-6189-7259
David GrevensteinClinic and Polyclinic for Orthopedics and Trauma Surgery, University Hospital of Cologne, 50937 Cologne, Germany.ORCID 0000-0003-4823-7739
Willi WagnerDepartment of Diagnostic and Interventional Radiology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Maximilian BabelInstitute of Pathology, University of Regensburg, 93053 Regensburg, Germany.
Karsten KellerDepartment of Cardiology, University Medical Centre, Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.ORCID 0000-0002-0820-9584
Christine SchmittDepartment of Internal Medicine, St. Vincenz and Elisabeth Hospital of Mainz (KKM), 55131 Mainz, Germany.
Florian GürtlerInstitute of Pathology, University of Regensburg, 93053 Regensburg, Germany.
Stephan SchremlDepartment of Dermatology, University Medical Centre Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-2820-1942
Tanja NiedermairInstitute of Pathology, University of Regensburg, 93053 Regensburg, Germany.
Markus RuppDepartment for Trauma Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-7221-3783
Volker AltDepartment for Trauma Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0003-0208-4650
Christoph BrochhausenInstitute of Pathology, University of Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-6761-0247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The understanding of macrophages and their pathophysiological role has dramatically changed within the last decades. Macrophages represent a very interesting cell type with regard to biomaterial-based tissue engineering and regeneration. In this context, macrophages play a crucial role in the biocompatibility and degradation of implanted biomaterials. Furthermore, a better understanding of the functionality of macrophages opens perspectives for potential guidance and modulation to turn inflammation into regeneration. Such knowledge may help to improve not only the biocompatibility of scaffold materials but also the integration, maturation, and preservation of scaffold-cell constructs or induce regeneration. Nowadays, macrophages are classified into two subpopulations, the classically activated macrophages (M1 macrophages) with pro-inflammatory properties and the alternatively activated macrophages (M2 macrophages) with anti-inflammatory properties. The present narrative review gives an overview of the different functions of macrophages and summarizes the recent state of knowledge regarding different types of macrophages and their functions, with special emphasis on tissue engineering and tissue regeneration.

Indexed as

Biocompatible MaterialsMacrophagesHumansInflammationTissue EngineeringWound HealingBiocompatible MaterialsbiomaterialsinflammationM1-macrophagesM2-macrophagesmacrophagemonocytesplasticitytissue regeneration

Identifiers

PMID36672212
PMCPMC9856654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.